Literature DB >> 9219227

Ribozymes. Their functions and strategies for their use.

S A Gibson1, E J Shillitoe.   

Abstract

The ability to alter genes in order to regulate their expression has become an undeniable reality. This can be performed in vitro and in cells, and the possibility of treating diseases and even preventing them now exists through such gene manipulation. A particularly intriguing form of manipulation that has been investigated for just over a decade is one that involves the use of ribozymes. These are short segments of RNA that form complementary base-pairing with mRNA. However, it is their enzymatic properties that set them apart from other antisense RNA molecules and allow them to cleave and destroy mRNA in a very specific manner. The ribozyme then dissociates from the cleaved substrate RNa, and repeatedly hybridizes to and cleaves additional substrate RNA molecules. Problems being addressed as this technology evolves involve optimization of ribozyme:substrate binding efficiencies and their effective transmission into cells. This article points out the origin of ribozymes, analyzes and summarizes the current strategies for designing ribozymes, and outlines a basic procedure for ribozyme development.

Mesh:

Substances:

Year:  1997        PMID: 9219227     DOI: 10.1007/BF02761748

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  55 in total

1.  Extended target-site specificity for a hammerhead ribozyme.

Authors:  R Perriman; A Delves; W L Gerlach
Journal:  Gene       Date:  1992-04-15       Impact factor: 3.688

2.  Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene.

Authors:  M Koizumi; H Kamiya; E Ohtsuka
Journal:  Gene       Date:  1992-08-15       Impact factor: 3.688

3.  Substrate sequence effects on "hammerhead" RNA catalytic efficiency.

Authors:  M J Fedor; O C Uhlenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.

Authors:  M Ishizaka; Y Ohshima; T Tani
Journal:  Biochem Biophys Res Commun       Date:  1995-09-14       Impact factor: 3.575

5.  RNA stem stability in the formation of a self-cleaving hammerhead structure.

Authors:  C C Sheldon; R H Symons
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

6.  A simple and efficient liposome method for transfection of DNA into mammalian cells grown in suspension.

Authors:  T Itani; H Ariga; N Yamaguchi; T Tadakuma; T Yasuda
Journal:  Gene       Date:  1987       Impact factor: 3.688

7.  The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme.

Authors:  C Guerrier-Takada; K Gardiner; T Marsh; N Pace; S Altman
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

8.  In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1.

Authors:  K Rittner; C Burmester; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

9.  Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1.

Authors:  M Homann; S Tzortzakaki; K Rittner; G Sczakiel; M Tabler
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

10.  Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme.

Authors:  M Feng; G Cabrera; J Deshane; K J Scanlon; D T Curiel
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  2 in total

Review 1.  Genetic targeting of the renin-angiotensin system for long-term control of hypertension.

Authors:  Beverly L Metcalfe; Mohan Raizada; Michael J Katovich
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

2.  Preparation and identification of anti-transforming growth factor beta1 U1 small nuclear RNA chimeric ribozyme in vitro.

Authors:  Ju-Sheng Lin; Yu-Hu Song; Xin-Juan Kong; Bin Li; Nan-Zhi Liu; Xiao-Li Wu; You-Xin Jin
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.